UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 127

Sortiert nach

Grössenprogredientes Ulkus infraaurikulär links

HNO, 2008-10, Vol.56 (10), p.1054-1056

2008

Volltextzugriff (PDF)

Résultats actualisés de survie sans maladie (DFS) de l’essai de phase 3 CheckMate 274, évaluant le nivolumab en adjuvant chez les patients atteints d’un carcinome urothélial infiltrant le muscle à haut risque de récidive (CUIM-HR) après exérèse complète

Progrès en urologie. Formation médicale continue, 2022-11, Vol.32 (3), p.S97-S98

2022

Volltextzugriff (PDF)

UP02 - Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer

European urology open science (Online), 2023-10, Vol.56, p.S21-S21

2023

Volltextzugriff (PDF)

Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer

European urology open science (Online), 2023-10, Vol.56, p.S21

2023

Volltextzugriff (PDF)

637P The prognostic value of the baseline neutrophil-to-lymphocyte ratio (NLR) in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving radium-223 (Ra-223): A post-hoc analysis of the ALSYMPCA phase-III trial

Annals of oncology, 2020-09, Vol.31, p.S524-S525

2020

Volltextzugriff (PDF)

Tumor and immune features associated with disease-free survival with adjuvant nivolumab in the phase 3 CheckMate 274 trial

European urology open science (Online), 2022-11, Vol.45, p.S239-S240

2022

Volltextzugriff (PDF)

1454P Optimizing ipilimumab in RCC: Results from SAKK 07/17 (CM-980) nivolumab (N) + ipilimumab (Ipi) in mRCC

Annals of oncology, 2022-09, Vol.33, p.S1209

2022

Volltextzugriff (PDF)

PROGNOSTIC FACTORS IN ELDERLY PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA ‐ A JOINT ANALYSIS OF TWO CLINICAL DATABASES

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

6655 The emerging role of the novel serum marker GOLPH2 in detecting and monitoring of hepatocellular carcinoma

European journal of cancer supplements, 2009, Vol.7 (2), p.404-405

2009

Volltextzugriff (PDF)

1279P The prognostic value of chemotherapy-induced neutropenia (CIN) in patients with advanced non-small cell lung cancer (NSCLC) in the era of chemoimmunotherapy (CIT)

Annals of oncology, 2021-09, Vol.32, p.S996-S996

2021

Volltextzugriff (PDF)

1737MO Tumor and immune features associated with disease-free survival with adjuvant nivolumab in the phase III CheckMate 274 trial

Annals of oncology, 2022-09, Vol.33, p.S1331

2022

Volltextzugriff (PDF)

1051P Radiotherapy (RT) and efficacy of immune checkpoint inhibitors (ICI), chemotherapy (CTx) and chemoimmunotherapy (CIT) in patients with non-small cell lung cancer (NSCLC)

Annals of oncology, 2022-09, Vol.33, p.S1035-S1036

2022

Volltextzugriff (PDF)

716P Optimizing ipilimumab in metastatic renal cell carcinoma: SAKK 07/17 study

Annals of oncology, 2020-09, Vol.31, p.S563-S563

2020

Volltextzugriff (PDF)

Antigen-specific in vitro expansion of functional redirected NY-ESO-1-specific human CD8+ T-cells in a cell-free system

Anticancer research, 2013-10, Vol.33 (10), p.4189-4201

2013

Volltextzugriff (PDF)

After care in Hodgkin lymphoma

Praxis (Bern. 1994), 2011-12, Vol.100 (25), p.1515

2011

Volltextzugriff (PDF)

Größenprogredientes Ulkus infraaurikulär links

HNO, 2008, Vol.56 (10), p.1054-1056

2008

Volltextzugriff (PDF)

The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40

Cancer research (Chicago, Ill.), 1996-10, Vol.56 (20), p.4766-4772

1996

Volltextzugriff (PDF)

28P 3-year follow-up analysis of disease-free survival in CheckMate 274 by PD-L1 expression using tumor cell and combined positive scoring algorithms

Immuno-oncology technology, 2023-12, Vol.20, p.100497, Article 100497

2023

Volltextzugriff (PDF)

Treatment of POEMS syndrome with bevacizumab

Haematologica (Roma), 2007-10, Vol.92 (10), p.1438-1439

2007

Volltextzugriff (PDF)

A progressive ulcerative neck mass on the left infraauricular area

HNO, 2008-10, Vol.56 (10), p.1054-1056

2008

Volltextzugriff (PDF)

Characterization of the human GARP (Golgi associated retrograde protein) complex

Experimental cell research, 2005-05, Vol.306 (1), p.24-34

2005

Volltextzugriff (PDF)

Early Neutropenia is Associated with Survival in Men with Metastatic Castration-Resistant Prostate Cancer (Mcrpc) When Treated with Cabazitaxel: an Analysis of Tropic Phase III Trial

Annals of oncology, 2014-09, Vol.25, p.iv271

2014

Volltextzugriff (PDF)

Neutropenia grade ≥ 3 during treatment with docetaxel (DOC) is associated with an improved overall survival (OS): A retrospective analysis of the TAX327 phase III trial

Annals of oncology, 2016-10, Vol.27, p.vi256-vi256

2016

Volltextzugriff (PDF)

Siegenthalers Differenzialdiagnose

20., komplett überarbeitete und aktualisierte Auflage.

Volltextzugriff (PDF)

Everolimus as first-line therapy in nonrapidly progressive metastatic castration-resistant prostate cancer (mCRPC): A multicenter phase II trial (SAKK 08/08)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.4588-4588

2011

Volltextzugriff (PDF)

26 – 50 von 127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(118)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Grössenprogredientes Ulkus infraaurikulär links

Résultats actualisés de survie sans maladie (DFS) de l’essai de phase 3 CheckMate 274, évaluant le nivolumab en adjuvant chez les patients atteints d’un carcinome urothélial infiltrant le muscle à haut risque de récidive (CUIM-HR) après exérèse complète

UP02 - Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer

Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer

637P The prognostic value of the baseline neutrophil-to-lymphocyte ratio (NLR) in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving radium-223 (Ra-223): A post-hoc analysis of the ALSYMPCA phase-III trial

Tumor and immune features associated with disease-free survival with adjuvant nivolumab in the phase 3 CheckMate 274 trial

1454P Optimizing ipilimumab in RCC: Results from SAKK 07/17 (CM-980) nivolumab (N) + ipilimumab (Ipi) in mRCC

PROGNOSTIC FACTORS IN ELDERLY PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA ‐ A JOINT ANALYSIS OF TWO CLINICAL DATABASES

6655 The emerging role of the novel serum marker GOLPH2 in detecting and monitoring of hepatocellular carcinoma

1279P The prognostic value of chemotherapy-induced neutropenia (CIN) in patients with advanced non-small cell lung cancer (NSCLC) in the era of chemoimmunotherapy (CIT)

1737MO Tumor and immune features associated with disease-free survival with adjuvant nivolumab in the phase III CheckMate 274 trial

1051P Radiotherapy (RT) and efficacy of immune checkpoint inhibitors (ICI), chemotherapy (CTx) and chemoimmunotherapy (CIT) in patients with non-small cell lung cancer (NSCLC)

716P Optimizing ipilimumab in metastatic renal cell carcinoma: SAKK 07/17 study

Antigen-specific in vitro expansion of functional redirected NY-ESO-1-specific human CD8+ T-cells in a cell-free system

After care in Hodgkin lymphoma

Größenprogredientes Ulkus infraaurikulär links

The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40

28P 3-year follow-up analysis of disease-free survival in CheckMate 274 by PD-L1 expression using tumor cell and combined positive scoring algorithms

Treatment of POEMS syndrome with bevacizumab

A progressive ulcerative neck mass on the left infraauricular area

Characterization of the human GARP (Golgi associated retrograde protein) complex

Early Neutropenia is Associated with Survival in Men with Metastatic Castration-Resistant Prostate Cancer (Mcrpc) When Treated with Cabazitaxel: an Analysis of Tropic Phase III Trial

Neutropenia grade ≥ 3 during treatment with docetaxel (DOC) is associated with an improved overall survival (OS): A retrospective analysis of the TAX327 phase III trial

Siegenthalers Differenzialdiagnose

Everolimus as first-line therapy in nonrapidly progressive metastatic castration-resistant prostate cancer (mCRPC): A multicenter phase II trial (SAKK 08/08)

Suchergebnisse filtern